207 related articles for article (PubMed ID: 18566172)
21. Characterization of adrenal lesions with 1.5-T MRI: preliminary observations on comparison of three in-phase and out-of-phase gradient-echo techniques.
Ramalho M; de Campos RO; Heredia V; Dale BM; Tannaphai P; Azevedo RM; Semelka RC
AJR Am J Roentgenol; 2011 Aug; 197(2):415-23. PubMed ID: 21785088
[TBL] [Abstract][Full Text] [Related]
22. Characterization of adrenal lesions at chemical-shift MRI: a direct intraindividual comparison of in- and opposed-phase imaging at 1.5 T and 3 T.
Ream JM; Gaing B; Mussi TC; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Mar; 204(3):536-41. PubMed ID: 25714282
[TBL] [Abstract][Full Text] [Related]
23. Diffusion tensor imaging in the differentiation of adrenal adenomas and metastases.
Işık Y; Gürses B; Taşdelen N; Kılıçkesmez O; Fırat Z; Ordu C; Gürmen N
Diagn Interv Radiol; 2012; 18(2):189-94. PubMed ID: 21960162
[TBL] [Abstract][Full Text] [Related]
24. Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study.
Kuhl CK; Gieseke J; von Falkenhausen M; Textor J; Gernert S; Sonntag C; Schild HH
Radiology; 2005 Feb; 234(2):517-26. PubMed ID: 15671005
[TBL] [Abstract][Full Text] [Related]
25. Characterization of adrenal adenomas and metastases: correlation between unenhanced computed tomography and chemical shift magnetic resonance imaging.
Rescinito G; Zandrino F; Cittadini G; Santacroce E; Giasotto V; Neumaier CE
Acta Radiol; 2006 Feb; 47(1):71-6. PubMed ID: 16498936
[TBL] [Abstract][Full Text] [Related]
26. MR imaging of the adrenal glands: 1.5T versus 3T.
Merkle EM; Schindera ST
Magn Reson Imaging Clin N Am; 2007 Aug; 15(3):365-72, vii. PubMed ID: 17893056
[TBL] [Abstract][Full Text] [Related]
27. Adrenal masses: characterization with in vivo proton MR spectroscopy--initial experience.
Faria JF; Goldman SM; Szejnfeld J; Melo H; Kater C; Kenney P; Huayllas MP; Demarchi G; Francisco VV; Andreoni C; Srougi M; Ortiz V; Abdalla N
Radiology; 2007 Dec; 245(3):788-97. PubMed ID: 18024453
[TBL] [Abstract][Full Text] [Related]
28. Adrenal adenoma and metastasis from clear cell renal cell carcinoma: can they be differentiated using standard MR techniques?
Woo S; Cho JY; Kim SY; Kim SH
Acta Radiol; 2014 Nov; 55(9):1120-8. PubMed ID: 24252816
[TBL] [Abstract][Full Text] [Related]
29. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
[TBL] [Abstract][Full Text] [Related]
30. Characterization of adrenal tumors by chemical shift fast low-angle shot MR imaging: comparison of four methods of quantitative evaluation.
Fujiyoshi F; Nakajo M; Fukukura Y; Tsuchimochi S
AJR Am J Roentgenol; 2003 Jun; 180(6):1649-57. PubMed ID: 12760936
[TBL] [Abstract][Full Text] [Related]
31. A prospective study on the utility of diffusion-weighted and quantitative chemical-shift magnetic resonance imaging in the distinction of adrenal adenomas and metastases.
Halefoglu AM; Altun I; Disli C; Ulusay SM; Ozel BD; Basak M
J Comput Assist Tomogr; 2012; 36(4):367-74. PubMed ID: 22805662
[TBL] [Abstract][Full Text] [Related]
32. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
33. [Magnetic resonance in the study of suprarenal neoplasms. Qualitative and quantitative analysis of signal intensity].
Maurea S; Caracò C; Castelli L; Filice S; Alfano B; Ruffolo F; Ziviello M; Salvatore M
Radiol Med; 1998 Mar; 95(3):199-207. PubMed ID: 9638166
[TBL] [Abstract][Full Text] [Related]
34. Quantitative evaluation of norcholesterol scintigraphy, CT attenuation value, and chemical-shift MR imaging for characterizing adrenal adenomas.
Yoh T; Hosono M; Komeya Y; Im SW; Ashikaga R; Shimono T; Tsuchiya N; Okada M; Hanada K; Yagyu Y; Nishimura Y; Murakami T
Ann Nucl Med; 2008 Jul; 22(6):513-9. PubMed ID: 18670858
[TBL] [Abstract][Full Text] [Related]
35. Characterization of adrenal masses using MR imaging with histopathologic correlation.
Heinz-Peer G; Hönigschnabl S; Schneider B; Niederle B; Kaserer K; Lechner G
AJR Am J Roentgenol; 1999 Jul; 173(1):15-22. PubMed ID: 10397092
[TBL] [Abstract][Full Text] [Related]
36. Diffusion-weighted echo-planar MRI: a valuable tool for differentiating primary parotid gland tumors?
Habermann CR; Gossrau P; Graessner J; Arndt C; Cramer MC; Reitmeier F; Jaehne M; Adam G
Rofo; 2005 Jul; 177(7):940-5. PubMed ID: 15973595
[TBL] [Abstract][Full Text] [Related]
37. Liver: segment-specific analysis of B1 field homogeneity at 3.0-T MR imaging with single-source versus dual-source parallel radiofrequency excitation.
Pazahr S; Fischer MA; Chuck N; Luechinger R; Schick F; Nanz D; Boss A
Radiology; 2012 Nov; 265(2):591-9. PubMed ID: 22929333
[TBL] [Abstract][Full Text] [Related]
38. Synthetic-echo time postprocessing technique for generating images with variable T2-weighted contrast: diagnosis of meniscal and cartilage abnormalities of the knee.
Andreisek G; White LM; Theodoropoulos JS; Naraghi A; Young N; Zhao CY; Mamisch TC; Sussman MS
Radiology; 2010 Jan; 254(1):188-99. PubMed ID: 20032152
[TBL] [Abstract][Full Text] [Related]
39. MR imaging of the liver: comparison between single-shot echo-planar and half-Fourier rapid acquisition with relaxation enhancement sequences.
Yamashita Y; Tang Y; Namimoto T; Mitsuzaki K; Takahashi M
Radiology; 1998 May; 207(2):331-7. PubMed ID: 9577477
[TBL] [Abstract][Full Text] [Related]
40. Chemical shift MR imaging of hyperattenuating (>10 HU) adrenal masses: does it still have a role?
Haider MA; Ghai S; Jhaveri K; Lockwood G
Radiology; 2004 Jun; 231(3):711-6. PubMed ID: 15118113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
